Paul Kiptoo

955 total citations
26 papers, 695 citations indexed

About

Paul Kiptoo is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Paul Kiptoo has authored 26 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Molecular Biology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Paul Kiptoo's work include Immunotherapy and Immune Responses (9 papers), T-cell and B-cell Immunology (7 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Paul Kiptoo is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), T-cell and B-cell Immunology (7 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Paul Kiptoo collaborates with scholars based in United States, Canada and Indonesia. Paul Kiptoo's co-authors include Teruna J. Siahaan, Audra L. Stinchcomb, Marlyn Dian Laksitorini, Peter A. Crooks, Vivitri Dewi Prasasty, Ngoc On, Donald W. Miller, Todd D. Williams, Dana C. Hammell and Kalpana S. Paudel and has published in prestigious journals such as Journal of Controlled Release, Journal of Pharmacology and Experimental Therapeutics and International Journal of Pharmaceutics.

In The Last Decade

Paul Kiptoo

26 papers receiving 680 citations

Peers

Paul Kiptoo
Kang Choon Lee South Korea
Elisa Toropainen Finland
Eliisa Mannermaa Finland
Zhihang Yang China
Yunlong Fan China
Amir P. Tamiz United States
Eva M. del Amo Finland
Philippe Daull France
Hovhannes J. Gukasyan United States
Xiao Kuang China
Kang Choon Lee South Korea
Paul Kiptoo
Citations per year, relative to Paul Kiptoo Paul Kiptoo (= 1×) peers Kang Choon Lee

Countries citing papers authored by Paul Kiptoo

Since Specialization
Citations

This map shows the geographic impact of Paul Kiptoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Kiptoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Kiptoo more than expected).

Fields of papers citing papers by Paul Kiptoo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Kiptoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Kiptoo. The network helps show where Paul Kiptoo may publish in the future.

Co-authorship network of co-authors of Paul Kiptoo

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Kiptoo. A scholar is included among the top collaborators of Paul Kiptoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Kiptoo. Paul Kiptoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kiptoo, Paul, et al.. (2022). Immune Modulation by Antigenic Peptides and Antigenic Peptide Conjugates for Treatment of Multiple Sclerosis. Medical Research Archives. 10(5). 3 indexed citations
2.
Singh, Rakesh K., Leon van Haandel, Paul Kiptoo, et al.. (2019). Methotrexate disposition, anti-folate activity and efficacy in the collagen-induced arthritis mouse model. European Journal of Pharmacology. 853. 264–274. 19 indexed citations
3.
Kopec, Brian M., Paul Kiptoo, Liqin Zhao, Eduardo Rosa‐Molinar, & Teruna J. Siahaan. (2019). Noninvasive Brain Delivery and Efficacy of BDNF to Stimulate Neuroregeneration and Suppression of Disease Relapse in EAE Mice. Molecular Pharmaceutics. 17(2). 404–416. 24 indexed citations
4.
On, Ngoc, et al.. (2017). Improving Brain Delivery of Biomolecules via BBB Modulation in Mouse and Rat: Detection using MRI, NIRF, and Mass Spectrometry. Nanotheranostics. 1(2). 217–231. 24 indexed citations
5.
Khedri, Zahra, et al.. (2017). Synthesis of a Bifunctional Peptide Inhibitor–IgG1 Fc Fusion That Suppresses Experimental Autoimmune Encephalomyelitis. Bioconjugate Chemistry. 28(7). 1867–1877. 9 indexed citations
6.
Alaofi, Ahmed L., Ngoc On, Paul Kiptoo, et al.. (2016). Comparison of Linear and Cyclic His-Ala-Val Peptides in Modulating the Blood-Brain Barrier Permeability: Impact on Delivery of Molecules to the Brain. Journal of Pharmaceutical Sciences. 105(2). 797–807. 26 indexed citations
7.
Laksitorini, Marlyn Dian, Paul Kiptoo, Ngoc On, et al.. (2015). Modulation of Intercellular Junctions by Cyclic-ADT Peptides as a Method to Reversibly Increase Blood–Brain Barrier Permeability. Journal of Pharmaceutical Sciences. 104(3). 1065–1075. 38 indexed citations
8.
On, Ngoc, Paul Kiptoo, Teruna J. Siahaan, & Donald W. Miller. (2014). Modulation of Blood–Brain Barrier Permeability in Mice Using Synthetic E-Cadherin Peptide. Molecular Pharmaceutics. 11(3). 974–981. 39 indexed citations
9.
Manikwar, Prakash, et al.. (2012). Vaccinelike and Prophylactic Treatments of EAE with Novel I-Domain Antigen Conjugates (IDAC): Targeting Multiple Antigenic Peptides to APC. Molecular Pharmaceutics. 10(1). 297–306. 3 indexed citations
10.
Manikwar, Prakash, et al.. (2011). Antigen‐specific blocking of CD4‐Specific immunological synapse formation using BPI and current therapies for autoimmune diseases. Medicinal Research Reviews. 32(4). 727–764. 26 indexed citations
11.
Kiptoo, Paul, Wen‐Tung Wang, In‐Young Choi, et al.. (2011). Suppression of EAE and prevention of blood–brain barrier breakdown after vaccination with novel bifunctional peptide inhibitor. Neuropharmacology. 62(4). 1874–1881. 25 indexed citations
12.
Kiptoo, Paul, et al.. (2009). Immune response to controlled release of immunomodulating peptides in a murine experimental autoimmune encephalomyelitis (EAE) model. Journal of Controlled Release. 141(2). 145–152. 23 indexed citations
13.
Kiptoo, Paul, Naoki Kobayashi, Scott J. Weir, et al.. (2009). Antigen-Specific Suppression of Experimental Autoimmune Encephalomyelitis by a Novel Bifunctional Peptide Inhibitor: Structure Optimization and Pharmacokinetics. Journal of Pharmacology and Experimental Therapeutics. 332(3). 1136–1145. 22 indexed citations
14.
Kiptoo, Paul, Kalpana S. Paudel, Dana C. Hammell, et al.. (2008). Transdermal Delivery of Bupropion and its Active Metabolite, Hydroxybupropion: A Prodrug Strategy as an Alternative Approach. Journal of Pharmaceutical Sciences. 98(2). 583–594. 24 indexed citations
15.
Kiptoo, Paul, et al.. (2008). In vivo evaluation of a transdermal codrug of 6-β-naltrexol linked to hydroxybupropion in hairless guinea pigs. European Journal of Pharmaceutical Sciences. 33(4-5). 371–379. 21 indexed citations
16.
Kobayashi, Naoki, et al.. (2008). Prophylactic and therapeutic suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor. Clinical Immunology. 129(1). 69–79. 25 indexed citations
17.
Kiptoo, Paul, et al.. (2006). Enhancement of transdermal delivery of 6-β-naltrexol via a codrug linked to hydroxybupropion. Journal of Controlled Release. 113(2). 137–145. 34 indexed citations
18.
19.
Paudel, Kalpana S., Buchi N. Nalluri, Dana C. Hammell, et al.. (2005). Transdermal Delivery of Naltrexone and its Active Metabolite 6-β-Naltrexol in Human Skin in Vitro and Guinea Pigs in Vivo. Journal of Pharmaceutical Sciences. 94(9). 1965–1975. 30 indexed citations
20.
Valiveti, Satyanarayana, Paul Kiptoo, Dana C. Hammell, & Audra L. Stinchcomb. (2004). Transdermal permeation of WIN 55,212-2 and CP 55,940 in human skin in vitro. International Journal of Pharmaceutics. 278(1). 173–180. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kang Choon Lee Breakdown of academic impact, for papers by Elisa Toropainen Breakdown of academic impact, for papers by Eliisa Mannermaa Breakdown of academic impact, for papers by Zhihang Yang Breakdown of academic impact, for papers by Yunlong Fan Breakdown of academic impact, for papers by Amir P. Tamiz Breakdown of academic impact, for papers by Eva M. del Amo Breakdown of academic impact, for papers by Philippe Daull Breakdown of academic impact, for papers by Hovhannes J. Gukasyan Breakdown of academic impact, for papers by Xiao Kuang
Rankless by CCL
2026